International

SNMMI is a global and collaborative scientific organization dedicated to both the practice and the science of nuclear medicine and molecular imaging and therapy around the world. SNMMI's worldwide membership totals more than 17,000, including physicians, scientists, technologists, chemists, radiopharmacists, students and industry representatives from 76 countries around the world.

Instant Access to 2017 Annual Meeting Research Presentations and Sessions

Access 100 popular sessions from the 2017 Annual Meeting.

The Virtual Meeting is an online product (with an optional USB) that includes access to 100 recorded sessions from SNMMI's 2017 Annual Meeting. Learn More.

Highlights include:

  • 24/7 online, anywhere access
  • CME, ACPE and VOICE credit available for selected sessions
  • Synchronized slides and audio of the most popular sessions
  • Includes the Plenary Sessions and Henry N. Wagner, Jr., MD Highlights Symposium
  • Convenient mobile viewing on your Apple® and Android™ devices 

Access research presentations from the 2017 Annual Meeting.

The Virtual Poster Hall is an online product that includes access to hundreds of Scientific Abstract Oral and Poster Presentations from SNMMI's 2017 Annual Meeting. Learn More.

Highlights include:

  • 24/7 online, anywhere access
  • Browse and search by author, country, keyword, session, and topic
  • Add your comments/questions
  • Bookmark your favorite presentations for easy future access.

A Global Organization

SNMMI is a global and collaborative scientific organization dedicated to both the practice and the science of nuclear medicine and molecular imaging and therapy around the world. SNMMI's worldwide membership totals over 20,000, which includes physicians, scientists, technologists, chemists, radiopharmacists, students and industry representatives from more than 84 countries around the world. SNMMI's Journal of Nuclear Medicine (JNM), the premier international journal of nuclear medicine, reaches over 17,000 individuals each month. SNMMI's Annual Meeting is nuclear medicine's and molecular imaging's largest gathering each year, attracting over 5,000 professional attendees and another 2,500 industry representatives.

At the most recent Annual Meeting in June 2016 in San Diego, California, 35% of registered attendees were from countries other than the United States. Attendees represented over 65 countries. In addition, abstract submissions for SNMMI's Annual Meeting from outside the United States represent close to 67% of all submissions.

SNMMI Headquarters
While SNMMI's headquarters office resides in Virginia, just outside of Washington, D.C., its perspective, programs, and growth are as international as its members. As of 2017, 12% of the Society's members reside in more than 84 countries other than the United States.

Search for an international nuclear medicine and molecular imaging organization near you.

SNMMI's Programs and Activities 

SNMMI's educational programs and activities reflect the increasing importance and participation of its international members. Such common global nuclear medicine and molecular imaging and therapy issues as quality of care, educating referring physicians and patients, and exploring ways to better share developments in the practice of nuclear medicine and molecular imaging and therapy are but a few of the activities currently underway by Society staff, Committees, Councils, and our Centers of Excellence. This website seeks to constantly expand its offerings to the Society's international members, providing an ever-changing, updated array of global resources and news for nuclear medicine and molecular imaging and therapy professionals literally anywhere on the globe.

SNMMI continues to stay actively involved in several jointly sponsored educational programs and educational outreach activities with regional nuclear medicine and molecular imaging and therapy organizations around the world; both in their home countries, and during SNMMI's Annual Meeting. These joint sponsored programs include not only the sharing of speakers and renown experts on all facets of nuclear medicine and molecular imaging, collaboration on the development of enduring educational materials, and programmatic/administrative support, but also include translation of materials and website development.


Each year, the SNMMI collaborates with international organizations in an effort to continue the exchange of ideas, education and knowledge. Intiatives include:

Nuclear Medicine Global Initiative
3rd Sino-American Conference
Chinese/U.S. Resident Exchange Program
Wagner-Torizuka Fellowship
IAEA CT Case Webinar Series
EANM Collaborative Guidelines

Membership

SNMMI offers a Full International Membership category for international colleagues. Learn more on how to become an SNMMI Full Member (international).

Full Member

(International)

Available to physicians, scientists or pharmacists possessing an advanced degree who have presented credentials indicating their professional activity, either, medical, paramedical, investigational or educational in the scientific or clinical disciplines of molecular imaging or nuclear medicine. This includes the diagnostic, therapeutic or investigational use of radionuclides or other molecular imaging technologies.

Annual dues: $510

Includes subscription to The Journal of Nuclear Medicine.

Includes voting rights and can be elected an Officer of the SNMMI.

Corresponding Country Discount

(View list of eligible countries)

 

In an effort to make membership more accessible to nuclear medicine and molecular imaging professionals around the world, SNMMI’s corresponding country category gives members of eligible countries an 80% discount on dues. See discount breakdown.

80% discount on all membership categories

Online access to The Journal of Nuclear Medicine.

Voting rights and can be elected an Officer of the SNMMI.

 

Strategic Alliances: Partnering for Nuclear Medicine and Molecular Imaging's Global Growth

As part of its continuing commitment to growing the practice of nuclear medicine and molecular imaging and therapy worldwide, SNMMI leadership works diligently to develop strategic alliances with key regional nuclear medicine organizations to assist these groups in expanding the scope and quality of nuclear medicine outside the United States. These strategic alliances stretch across the globe. reaching every continent where SNMMI's members reside and practice.

SNMMI Partners and Alliances Include:

Contact Us

For more information on SNMMI's international activities and programs, please contact:

Nikki Wenzel-Lamb, MBA Director of Leadership Direct: 703-652-6766 Fax: 703-708-9020 Email: nwenzel@snmmi.org

  • September 19, 2017NRC Advisory Committee on Medical Uses of Isotopes Fall Meeting Summary

    The Nuclear Regulatory Commission (NRC) held their fall meeting of the Advisory Committee on Medical Uses of Isotopes (ACMUI) on September 11 and 12, 2017.
    (Government Relations News)

  • September 14, 2017New Book Available on Abdominal Imaging

    "Abdominal Imaging 2017: Quality, Safety, & Dose Optimization" is the second installment in a series of books dedicated to a single nuclear medicine procedure or imaging category. The book is put out by the SNMMI-TS Publications Committee, and chapters cover imaging rationale, indications, contraindications, patient preparation and education, imaging procedure, processing, interpretation including normal and abnormal results, sensitivity/specificity/accuracy, and artifacts.
    (SNMMI News)

  • September 13, 2017Theranostics: Paintball Targeting of Cancer Cells Combined with Precision Therapy

    The Journal of Nuclear Medicine’s September supplement shines a spotlight on theranostics and its increasingly important role in delivering precision medicine. Theranostics refers to the combination of a predictive biomarker, identified through diagnostic imaging using radiolabeled ligands, with precise therapy targeted on the now-marked cancer cells. The cancer cells are destroyed, while healthy cells are unharmed.
    (Press Release)

  • September 12, 2017International Isotopes Inc. Announces Dr. Robert Atcher Has Joined The Company Board of Directors

    International Isotopes Inc. has announced that Robert W. Atcher, PhD, MBA, FSNMMI has accepted a position on the company's Board of Directors. Atcher recently retired from Los Alamos National Laboratory where, for over 20 years, he worked on various medical applications for isotopes. He currently serves as president of the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF).
    (Member News)

Spotlight

Featured Resources